UK markets closed
NIKKEI 225
27,606.46 -79.01 (-0.29%) HANG SENG
21,283.52 -15.18 (-0.07%) CRUDE OIL
78.49 +1.35 (+1.75%) GOLD FUTURES
1,886.90 +2.10 (+0.11%) DOW
33,970.34 -186.35 (-0.55%) BTC-GBP
18,960.51 -343.60 (-1.78%)
Centessa Pharmaceuticals plc (CNTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:40PM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 366.09M |
| Enterprise value | -10.56M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.98 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 1.03 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -65.49% |
| S&P500 52-week change 3 | -9.23% |
| 52-week high 3 | 11.1900 |
| 52-week low 3 | 2.8850 |
| 50-day moving average 3 | 3.6342 |
| 200-day moving average 3 | 4.4245 |
Share statistics
| Avg vol (3-month) 3 | 119.1k |
| Avg vol (10-day) 3 | 226.82k |
| Shares outstanding 5 | 94.6M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 35.15M |
| % held by insiders 1 | 3.37% |
| % held by institutions 1 | 80.38% |
| Shares short (12 Jan 2023) 4 | 1.81M |
| Short ratio (12 Jan 2023) 4 | 17.16 |
| Short % of float (12 Jan 2023) 4 | N/A |
| Short % of shares outstanding (12 Jan 2023) 4 | 1.92% |
| Shares short (prior month 14 Dec 2022) 4 | 1.86M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -25.56% |
| Return on equity (ttm) | -50.71% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -223.1M |
| Net income avi to common (ttm) | -233.81M |
| Diluted EPS (ttm) | -2.2950 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 444.84M |
| Total cash per share (mrq) | 4.7 |
| Total debt (mrq) | 68.2M |
| Total debt/equity (mrq) | 18.29 |
| Current ratio (mrq) | 12.49 |
| Book value per share (mrq) | 3.94 |
Cash flow statement
| Operating cash flow (ttm) | -205.41M |
| Levered free cash flow (ttm) | -111.9M |
© 2023 Yahoo. All rights reserved.
